European Companies Search Engine
Managing Director (1) · Name: Curacyte Discovery GmbH · Corporate Purpose Hrb 2 Jun 2005 German Trade Register Announcements, Germany (27/05/2005)
Overview
Text
IBFB Pharma GmbH, Leipzig (
Unnamed street ??, 04103 Leipzig, Germany
). The Shareholders' Meeting of 27 April 2005 decided to amend Section 1 (Company and Headquarters - Regarding Company) 2 (Object of the Company), 6, 7 (Management and Representation) as well as the replacement of the previous Sections 8-12 (to the Supervisory Board) of the Social Agreement. In addition, the statutes have been redrafted. New company: Curacyte Discovery GmbH. New object: establishment and operation of a private, carrier-independent development, research, production and advisory institution, applicative research and development work in the pharmacological, biomedical and cosmetic fields, in particular the development of drug candidates as enzyme inhibitors for their therapeutic use in human and veterinary medicine; the production and distribution of products from the biomedical field and the preparation of expert opinions and scientific advice for companies and individuals and qualification measures. The excluded are trades and transactions subject to authorisation in accordance with kWG as well as legal and tax advice. Appointed: Managing Director: Dr. ????, ???????, Leipzig, *??.??.????, authorized to represent one person; with the power to enter into legal transactions on behalf of the company in its own name or a.s. a representative of a third party.
This filing was translated from German to English. The filing refers to a past date, and does not necessarily reflect the current state. The latest known state is available on the following page: The Medicines Company (Leipzig) GmbH, Leipzig, Germany.